G.Barekat Pharm (XTEH:BRKT1) Other Income (Expense) : IRR Mil (TTM As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Other Income (Expense)?

G.Barekat Pharm's other income expense for the G.Barekat Pharm's pretax income for the six months ended in Mar. 2017 was IRR2,212,777 Mil.

G.Barekat Pharm Other Income (Expense) Historical Data

The historical data trend for G.Barekat Pharm's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Other Income (Expense) Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Other Income (Expense)

1,373,173.00

2,212,777.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Other Income (Expense)	1,373,173.00	2,212,777.00

G.Barekat Pharm Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

G.Barekat Pharm (XTEH:BRKT1) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines